Original Research
Published on 18 Mar 2021
Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer
in Molecular and Cellular Oncology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2021.646982
- 6,459 views
- 12 citations
